-+ 0.00%
-+ 0.00%
-+ 0.00%

TOLERANCE BIO: PREPARING TO ADVANCE EFINEPTAKIN ALFA INTO PHASE 2 STUDIES

路透·08/19/2026 12:00:01

登录查看新闻详情